A Study of QLS31905 in Patients With Advanced Solid Tumors
NCT05278832
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
QLS31905
Sponsor
Qilu Pharmaceutical Co., Ltd.